Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Sales | 271,950 | 234,238 | 226,957 | 223,350 | 278,592 |
| Cost of Goods | 25,149 | 19,410 | 12,420 | 18,869 | 17,505 |
| Gross Profit | 246,801 | 214,828 | 214,537 | 204,481 | 261,087 |
| Operating Expenses | 168,343 | 161,699 | 156,663 | 154,774 | 156,674 |
| Operating Income | 78,607 | 53,539 | 58,294 | 50,576 | 104,918 |
| Interest Expense | 31 | 15 | -639 | 251 | 93 |
| Other Income | 1,309 | 792 | 1,729 | 1,489 | -1,903 |
| Pre-tax Income | 79,885 | 54,316 | 60,662 | 51,814 | 102,922 |
| Income Tax | 21,353 | 12,379 | 14,300 | 11,251 | 26,373 |
| Net Income Continuous | 58,532 | 41,937 | 46,362 | 40,563 | 76,549 |
| Minority Interests | 558 | 580 | 421 | 784 | 681 |
| Net Income | $57,974 | $41,357 | $45,941 | $39,779 | $75,868 |
| EPS Basic Total Ops | 0.57 | 0.40 | 0.45 | 0.39 | 0.74 |
| EPS Basic Continuous Ops | 0.57 | 0.41 | 0.45 | 0.40 | 0.75 |
| EPS Diluted Total Ops | 0.56 | 0.40 | 0.45 | 0.38 | 0.73 |
| EPS Diluted Continuous Ops | 0.56 | 0.40 | 0.45 | 0.39 | 0.74 |
| EBITDA(a) | $98,081 | $72,454 | $74,923 | $66,915 | $119,951 |